INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![Protocol Design Choices]( "Protocol Design Choices That Trigger IRB And Regulatory Requirements")
Protocol Design Choices That Trigger IRB And Regulatory RequirementsLearn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.
-
![Documentation-getty-1349390515]( "Go From Three Meetings To One With AI-Enabled eCOA")
Go From Three Meetings To One With AI-Enabled eCOALearn how to turn three meetings into one with AI that is streamlining clinical workflows by reducing redundant steps, simplifying site operations, and accelerating data collection.
-
![GettyImages-1180581753-scientists-lab-monitoring-computer-laboratory]( "Preparing The Next Generation Of Clinical Research Professionals")
Preparing The Next Generation Of Clinical Research ProfessionalsExplore the live EDC platform that enabled Durham Tech to create a model for future-forward, hands-on education in clinical research.
-
![GettyImages-1153115028-ocular-eye-exam]( "Ocular Hypertension In Clinical Trials: Protecting IOP Endpoints From Execution Risk")
Ocular Hypertension In Clinical Trials: Protecting IOP Endpoints From Execution RiskFluctuations in eye pressure measurements can jeopardize trial results. Learn how standardized execution and equipment calibration protect data integrity and regulatory credibility.
-
Patient App: One Place, One Login, And One Device8/5/2026
By simplifying trial participation, this app helps minimize dropouts and accelerate study timelines, empowering teams to execute smarter trials.
-
FDA Pushes For Patient Voice: ePRO In Oncology Trials1/8/2026
FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.
-
Overcoming Complex Patient Recruitment Challenges With Data4/15/2025
Overcome roadblocks to recruiting patients for rare disease clinical trials with RWD and RWE, including lack of diagnosis and stringent I/E criteria, geographic dispersion, and high dropout rates.
-
Everest Group Life Sciences eCOA Peak Matrix Assessment 20259/16/2025
Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.
-
Modern Data Platform Strategies That Accelerate Clinical Development11/26/2025
A modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![med-device-GettyImages-2211671827]( "High-Quality, ALCOA+ Device Data Under EU MDR And ISO 14155, Without Building A Data Management Team")
High-Quality, ALCOA+ Device Data Under EU MDR And ISO 14155, Without Building A Data Management TeamLean device team? Learn how expert data management and human-reviewed AI help you deliver high-quality clinical evidence for stronger regulatory submissions.
-
![gettyimages-2200665779-170667a-scientists-tablet-talking]( "Why Customers Are Switching To Medidata CTMS And eTMF")
Discover a CTMS that leads the market with top rankings and offers unmatched integration, automation, and user experience for faster, more efficient clinical trial execution.
-
![GettyImages-2203178449-pen-digital-tablet-modern]( "Streamline Data Capture And Automate EHR-To-EDC Data Transfer")
Streamline clinical trials by automating data transfer from EHRs to EDCs. Reduce site burden, minimize manual entry errors, and accelerate timelines to get critical insights faster.
-
![GettyImages-1311977468 site payments]( "Greenphire Patient Payments")
esigned for sponsors, CROs, sites, and patients, this modern solution delivers real-time data that supports crucial decisions during investigator grant budgeting, randomization, patient payments, and endpoint collection.
-
![GettyImages-1226390663-CRA- Clinical Research Associate]( "Starting A New Study? This One's For You")
Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.
